We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    medimmune rsv | Recruiting, Not yet recruiting, Available Studies
Previous Study | Return to List | Next Study

A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants. (MEDI8897 Ph2b)

This study is currently recruiting participants.
Verified November 2017 by MedImmune LLC
Sponsor:
ClinicalTrials.gov Identifier:
NCT02878330
First Posted: August 25, 2016
Last Update Posted: November 7, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
MedImmune LLC
  Purpose
The purpose of this study is to evaluate the efficacy, safety, pharmacokinetics (PK), and antidrug antibody (ADA) response for MEDI8897 in healthy preterm infants who are between 29 and 35 weeks gestational age and entering their first RSV season.

Condition Intervention Phase
Respiratory Syncytial Virus Infections Drug: MEDI8897 Drug: Placebo Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: A Phase 2b Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Preterm Infants

Resource links provided by NLM:


Further study details as provided by MedImmune LLC:

Primary Outcome Measures:
  • Incidence of medically attended LRTI due to RT-PCR confirmed RSV [ Time Frame: 150 days post dose ]
    The incidence of RSV LRTI (inpatient and outpatient) 150 days post dose will be based on RSV test results (performed centrally via RT-PCR) and objective clinical LRTI criteria and will be summarized by treatment group.


Secondary Outcome Measures:
  • Incidence of hospitalization due to Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) confirmed RSV [ Time Frame: 150 days post dose ]
    The incidence of RSV hospitalization 150 days post dose will be summarized by treatment group.

  • Safety and tolerability as assessed by the occurrence of all treatment emergent adverse events (TEAEs) and treatment emergent serious adverse events (TESAE) [ Time Frame: 360 days post dose ]

    Safety of MEDI8897 will primarily be assessed and measured by the occurrence of all treatment-emergent AEs and SAEs.

    Other safety assessments will include the occurence of Adverse Event of Special Interest (AESIs) and New Onset Chronic Diseases (NOCDs).


  • Single-dose serum concentrations of MEDI8897 [ Time Frame: 360 days post dose ]
    MEDI8897 serum concentration data will be tabulated by treatment group along with descriptive statistics. Terminal-phase half-life (t1/2) will be estimated using non-compartmental analysis, if data permit.

  • Incidence of anti-drug antibody (ADA) to MEDI8897 in serum [ Time Frame: 360 days post dose ]
    The incidence of ADA to MEDI8897 will be assessed and summarized by number and percentage of subjects that are ADA positive by treatment group.


Estimated Enrollment: 1500
Actual Study Start Date: November 3, 2016
Estimated Study Completion Date: November 30, 2018
Estimated Primary Completion Date: November 30, 2018 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: MEDI8897
Anti-RSV monoclonal antibody with an extended half-life
Drug: MEDI8897
Anti-RSV monoclonal antibody with an extended half-life
Placebo Comparator: Placebo
Commercially available 0.9% (w/v) saline.
Drug: Placebo
Commercially available 0.9% (w/v) saline.

Detailed Description:
This pivotal Phase 2b study will determine if MEDI8897 will be efficacious in reducing medically attended RSV-confirmed lower respiratory tract infections (LRTI) in healthy preterm infants entering their first RSV season. The population to be enrolled is healthy preterm infants born between 29 weeks 0 days and 34 weeks 6 days gestational age (GA) who would not receive RSV prophylaxis. A total of 1500 infants will be randomized 2:1 to receive either MEDI8897 or placebo. Subjects will be followed for 360 days after dosing. Enrollment is planned at approximately 197 sites across the USA, Canada, Europe, and the Southern Hemisphere.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 365 Days   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Key Inclusion Criteria:

  1. Healthy infants born between 29 weeks 0 days and 34 weeks 6 days GA
  2. Infants who are entering their first full RSV season at the time of screening

Key Exclusion Criteria:

  1. Meets American Academy of Pediatrics (AAP) or other local criteria to receive commercial palivizumab
  2. Any fever (≥ 100.4°F [≥ 38.0°C], regardless of route) or lower respiratory illness within 7 days prior to randomization
  3. Acute illness (defined as the presence of moderate or severe signs and symptoms) at the time of randomization
  4. Active RSV infection (a child with signs/symptoms of respiratory infection must have negative RSV testing) or known prior history of RSV infection
  5. Receipt of palivizumab or other RSV monoclonal antibody or any RSV vaccine, including maternal RSV vaccination
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02878330


Contacts
Contact: AstraZeneca Clinical Study Information Center 1-877-240-9479 information.center@astrazeneca.com

  Hide Study Locations
Locations
United States, Alabama
Research Site Recruiting
Birmingham, Alabama, United States, 35205
Research Site Recruiting
Huntsville, Alabama, United States, 35976
United States, Arkansas
Research Site Recruiting
Little Rock, Arkansas, United States, 72212
United States, California
Research Site Recruiting
Anaheim, California, United States, 92804
Research Site Recruiting
Anaheim, California, United States, 92805
Research Site Recruiting
Downey, California, United States, 90241
Research Site Recruiting
Huntington Beach, California, United States, 92647
Research Site Recruiting
Long Beach, California, United States, 90806
Research Site Withdrawn
Los Angeles, California, United States, 90015
Research Site Recruiting
Los Angeles, California, United States, 90027
Research Site Recruiting
Paramount, California, United States, 90723
Research Site Recruiting
San Diego, California, United States, 92123
Research Site Recruiting
West Covina, California, United States, 91790
United States, Colorado
Research Site Recruiting
Aurora, Colorado, United States, 80045
Research Site Recruiting
Colorado Springs, Colorado, United States, 80922
United States, Connecticut
Research Site Recruiting
Hartford, Connecticut, United States, 06106
United States, Florida
Research Site Recruiting
Gainesville, Florida, United States, 32607
Research Site Recruiting
Orlando, Florida, United States, 32804
Research Site Recruiting
Orlando, Florida, United States, 32806
Research Site Recruiting
South Miami, Florida, United States, 33143
United States, Georgia
Research Site Not yet recruiting
Atlanta, Georgia, United States, 30322
Research Site Recruiting
Augusta, Georgia, United States, 30912
United States, Illinois
Research Site Recruiting
Chicago, Illinois, United States, 60611
Research Site Recruiting
Oak Lawn, Illinois, United States, 60068
Research Site Recruiting
Park Ridge, Illinois, United States, 60068
United States, Indiana
Research Site Recruiting
South Bend, Indiana, United States, 46601
United States, Kansas
Research Site Recruiting
Topeka, Kansas, United States, 66604
United States, Massachusetts
Research Site Recruiting
Woburn, Massachusetts, United States, 01801
United States, Michigan
Research Site Recruiting
Detroit, Michigan, United States, 48201
United States, Minnesota
Research Site Recruiting
Duluth, Minnesota, United States, 55805
United States, Mississippi
Research Site Recruiting
Jackson, Mississippi, United States, 39216
United States, Missouri
Research Site Recruiting
Columbia, Missouri, United States, 65212
United States, Nebraska
Research Site Recruiting
Lincoln, Nebraska, United States, 68504
Research Site Recruiting
Omaha, Nebraska, United States, 68124
Research Site Recruiting
Omaha, Nebraska, United States, 68134
Research Site Recruiting
Omaha, Nebraska, United States, 68198
United States, New York
Research Site Recruiting
Liverpool, New York, United States, 13088
Research Site Recruiting
Mineola, New York, United States, 11501
Research Site Recruiting
New Hyde Park, New York, United States, 11040
Research Site Recruiting
Stony Brook, New York, United States, 11794
Research Site Recruiting
Syracuse, New York, United States, 13210-2306
United States, North Carolina
Research Site Recruiting
Boone, North Carolina, United States, 28607
Research Site Recruiting
Raleigh, North Carolina, United States, 27609
United States, Ohio
Research Site Recruiting
Cincinnati, Ohio, United States, 45229
Research Site Recruiting
Cincinnati, Ohio, United States, 45245
Research Site Not yet recruiting
Cleveland, Ohio, United States, 44106-6010
Research Site Recruiting
Cleveland, Ohio, United States, 44109
Research Site Recruiting
Columbus, Ohio, United States, 43205
Research Site Recruiting
Columbus, Ohio, United States, 43231
Research Site Recruiting
Dayton, Ohio, United States, 45414
Research Site Withdrawn
Toledo, Ohio, United States, 43606
United States, Oklahoma
Research Site Not yet recruiting
Oklahoma City, Oklahoma, United States, 73104
United States, Oregon
Research Site Recruiting
Gresham, Oregon, United States, 97030
United States, Pennsylvania
Research Site Recruiting
Erie, Pennsylvania, United States, 16506
Research Site Recruiting
Pittsburgh, Pennsylvania, United States, 15224
United States, South Carolina
Research Site Recruiting
Barnwell, South Carolina, United States, 29812
Research Site Recruiting
Charleston, South Carolina, United States, 29425
Research Site Recruiting
North Charleston, South Carolina, United States, 29406
United States, South Dakota
Research Site Recruiting
Sioux Falls, South Dakota, United States, 57104
United States, Tennessee
Research Site Recruiting
Kingsport, Tennessee, United States, 37660
Research Site Recruiting
Memphis, Tennessee, United States, 38103
Research Site Recruiting
Tullahoma, Tennessee, United States, 37388
United States, Texas
Research Site Recruiting
Baytown, Texas, United States, 77521
Research Site Not yet recruiting
Dallas, Texas, United States, 75235
Research Site Recruiting
Edinburg, Texas, United States, 78539
Research Site Recruiting
Fort Worth, Texas, United States, 76107
Research Site Recruiting
Galveston, Texas, United States, 77555
Research Site Recruiting
Longview, Texas, United States, 75604
Research Site Recruiting
San Antonio, Texas, United States, 78249
United States, Utah
Research Site Recruiting
Layton, Utah, United States, 84041
Research Site Recruiting
Orem, Utah, United States, 84057
Research Site Recruiting
Roy, Utah, United States, 84067
Research Site Recruiting
Syracuse, Utah, United States, 84075
United States, Washington
Research Site Recruiting
Seattle, Washington, United States, 98105
United States, West Virginia
Research Site Recruiting
Huntington, West Virginia, United States, 25701
Research Site Recruiting
Morgantown, West Virginia, United States, 26506
United States, Wisconsin
Research Site Not yet recruiting
Madison, Wisconsin, United States, 53792
Research Site Recruiting
Marshfield, Wisconsin, United States, 54449
Argentina
Research Site Recruiting
Bahía Blanca, Argentina, B8001HXM
Research Site Withdrawn
Ciudad Autónoma de Buenos Aire, Argentina, C1426BOR
Research Site Recruiting
Guaymallen Mendoza, Argentina, 5519
Research Site Withdrawn
San Miguel de Tucuman, Argentina, 4000
Australia
Research Site Recruiting
Clayton, Australia, 3168
Research Site Recruiting
Hobart, Australia, 7000
Research Site Recruiting
Melbourne, Australia, 3052
Research Site Recruiting
Subiaco, Australia, 6008
Research Site Recruiting
Westmead, Australia, 2145
Belgium
Research Site Recruiting
Gent, Belgium, 9000
Research Site Recruiting
Mons, Belgium, 7000
Brazil
Research Site Withdrawn
Belo Horizonte, Brazil, 30130-100
Research Site Recruiting
Botucatu, Brazil, 18618-970
Research Site Recruiting
Campinas, Brazil, 13084-791
Research Site Recruiting
Canoas, Brazil, 92425-900
Research Site Recruiting
Curitiba, Brazil, 80250-060
Research Site Recruiting
Juiz de Fora, Brazil, 36025-330
Research Site Recruiting
Passo Fundo, Brazil, 99010-080
Research Site Not yet recruiting
Porto Alegre, Brazil, 90035-074
Research Site Withdrawn
Recife, Brazil, 50070-550
Research Site Not yet recruiting
Sorocaba, Brazil, 18040-425
Bulgaria
Research Site Recruiting
Pleven, Bulgaria, 5800
Research Site Recruiting
Plovdiv, Bulgaria, 4002
Research Site Recruiting
Ruse, Bulgaria, 7002
Research Site Recruiting
Sofia, Bulgaria, 1407
Research Site Recruiting
Sofia, Bulgaria, 1431
Canada, Nova Scotia
Research Site Not yet recruiting
Halifax, Nova Scotia, Canada, B3K 6R8
Canada, Ontario
Research Site Recruiting
Newmarket, Ontario, Canada, L3Y 5G8
Canada, Quebec
Research Site Recruiting
Greenfield Park, Quebec, Canada, J4V 2H1
Research Site Recruiting
Montreal, Quebec, Canada, H4A 3J1
Chile
Research Site Recruiting
Maipu, Chile, 9250000
Research Site Recruiting
Santiago, Chile, 8053095
Research Site Recruiting
Santiago, Chile, 8380453
Research Site Recruiting
Santiago, Chile, 8420383
Research Site Recruiting
Santiago, Chile, 8880465
Research Site Withdrawn
Santiago, Chile
Research Site Recruiting
Valdivia, Chile, 5090000
Research Site Recruiting
Viña del Mar, Chile, 2520594
Czechia
Research Site Recruiting
Havlickuv Brod, Czechia, 580 22
Research Site Recruiting
Praha 4, Czechia, 14059
Research Site Recruiting
Praha 4, Czechia, 14710
Estonia
Research Site Recruiting
Tallinn, Estonia, 13419
Research Site Recruiting
Tartu, Estonia, 51014
Finland
Research Site Recruiting
Oulu, Finland, 90014
Research Site Recruiting
Tampere, Finland, 33100
Research Site Recruiting
Turku, Finland, 20520
France
Research Site Recruiting
Bordeaux, France, 33076
Research Site Recruiting
Brest, France, 29609
Research Site Recruiting
Bron, France, 69677
Research Site Recruiting
Caen Cedex, France, 14033
Research Site Recruiting
Dijon, France, 21079
Research Site Recruiting
Grenoble Cedex, France, 38043
Research Site Recruiting
Le Mans, France, 72000
Research Site Recruiting
MARSEILLE Cedex 20, France, 13015
Research Site Recruiting
Tours CEDEX 9, France, 37044
Hungary
Research Site Recruiting
Budapest, Hungary, 1062
Research Site Recruiting
Budapest, Hungary, 1094
Research Site Recruiting
Budapest, Hungary, 1131
Research Site Recruiting
Budapest, Hungary, 1204
Research Site Recruiting
Gyula, Hungary, 5700
Research Site Recruiting
Kecskemét, Hungary, 6000
Research Site Recruiting
Miskolc, Hungary, 3526
Research Site Recruiting
Nagykanizsa, Hungary, 8800
Research Site Recruiting
Nyireyghaza, Hungary, 4400
Research Site Recruiting
Sopron, Hungary, 9400
Research Site Recruiting
Szeged, Hungary, 6720
Research Site Recruiting
Szekszárd, Hungary, 7100
Research Site Recruiting
Veszprém, Hungary, 8200
Italy
Research Site Recruiting
Genova, Italy, 16147
Research Site Recruiting
Padova, Italy, 35128
Research Site Recruiting
Torino, Italy, 10126
Research Site Recruiting
Verona, Italy, 37126
Latvia
Research Site Recruiting
Jekabpils, Latvia, LV-5201
Research Site Recruiting
Riga, Latvia, LV1002
Research Site Recruiting
Valmiera, Latvia, 4200
Lithuania
Research Site Recruiting
Kaunas, Lithuania, 48259
Research Site Recruiting
Kaunas, Lithuania, 50161
Research Site Recruiting
Vilnius, Lithuania, 08406
New Zealand
Research Site Recruiting
Auckland, New Zealand, 2025
Research Site Recruiting
Christchurch, New Zealand, 8011
Research Site Recruiting
Wellington, New Zealand, 6021
Poland
Research Site Recruiting
Bydgoszcz, Poland, 85168
Research Site Recruiting
Gdansk, Poland, 80402
Research Site Recruiting
Krakow, Poland, 30-349
Research Site Recruiting
Krakow, Poland, 30-663
Research Site Recruiting
Leczna, Poland, 21-010
Research Site Not yet recruiting
Siemianowice Slaskie, Poland, 41-103
South Africa
Research Site Recruiting
Cape Town, South Africa, 7500
Research Site Recruiting
Cape Town, South Africa, 7700
Research Site Recruiting
Claremont, South Africa, 7708
Research Site Recruiting
Durban, South Africa, 4091
Research Site Recruiting
Johannesburg, South Africa, 2013
Research Site Recruiting
Johannesburg, South Africa, 2193
Research Site Recruiting
Pietermaritzburg, South Africa, 3201
Research Site Recruiting
Pretoria, South Africa, 0087
Spain
Research Site Recruiting
Alicante, Spain, 03010
Research Site Recruiting
Boadilla del Monte, Spain, 28660
Research Site Recruiting
Cordoba, Spain, 14004
Research Site Withdrawn
Donostia-San Sebastian, Spain, 20014
Research Site Recruiting
Granada, Spain, 18014
Research Site Recruiting
Lleida, Spain, 25198
Research Site Recruiting
Madrid, Spain, 28040
Research Site Recruiting
Madrid, Spain, 28046
Research Site Recruiting
Málaga, Spain, 29011
Research Site Not yet recruiting
San Juan de Alicante, Spain, 03550
Research Site Recruiting
Sant Cugat del Valles, Spain, 8190
Research Site Recruiting
Santiago de Compostela, Spain, 15706
Research Site Recruiting
Valencia, Spain, 46017
Sweden
Research Site Recruiting
Stockholm, Sweden, 118 83
Research Site Recruiting
Stockholm, Sweden, 171 76
Turkey
Research Site Recruiting
Adana, Turkey, 1260
Research Site Not yet recruiting
Ankara, Turkey, 06100
Research Site Recruiting
Antalya, Turkey, 07070
Research Site Recruiting
Izmir, Turkey, 35100
Research Site Not yet recruiting
Izmir, Turkey, 35210
Research Site Recruiting
Kocaeli, Turkey, 41380
Ukraine
Research Site Not yet recruiting
Chernivtsi, Ukraine, 58000
Research Site Not yet recruiting
Chernivtsi, Ukraine, 58001
Research Site Not yet recruiting
Dnipro, Ukraine, 49027
Research Site Not yet recruiting
Sumy, Ukraine, 40022
Research Site Not yet recruiting
Ternopil, Ukraine, 46023
Research Site Not yet recruiting
Vinnytsya, Ukraine, 21000
United Kingdom
Research Site Recruiting
Brighton, United Kingdom, BN2 5BE
Research Site Recruiting
Bristol, United Kingdom, BS2 8BJ
Research Site Recruiting
Liverpool, United Kingdom, L12 2AP
Research Site Recruiting
London, United Kingdom, SW17 0RE
Research Site Recruiting
Oxford, United Kingdom, OX3 7EJ
Research Site Recruiting
Southampton, United Kingdom, SO16 6YD
Sponsors and Collaborators
MedImmune LLC
  More Information

Responsible Party: MedImmune LLC
ClinicalTrials.gov Identifier: NCT02878330     History of Changes
Other Study ID Numbers: D5290C00003
First Submitted: August 22, 2016
First Posted: August 25, 2016
Last Update Posted: November 7, 2017
Last Verified: November 2017

Keywords provided by MedImmune LLC:
Respiratory Syncytial Virus, RSV
Preterm Infants
Lower Respiratory Tract Infection

Additional relevant MeSH terms:
Virus Diseases
Respiratory Syncytial Virus Infections
Pneumovirus Infections
Paramyxoviridae Infections
Mononegavirales Infections
RNA Virus Infections
Antibodies
Antibodies, Monoclonal
Immunologic Factors
Physiological Effects of Drugs